Genetic Factors Influencing Coagulation Factor XIII B-Subunit Contribute to Risk of Ischemic Stroke

Background and Purpose— Abnormal coagulation has been implicated in the pathogenesis of ischemic stroke, but how this association is mediated and whether it differs between ischemic stroke subtypes is unknown. We determined the shared genetic risk between 14 coagulation factors and ischemic stroke and its subtypes. Methods— Using genome-wide association study results for 14 coagulation factors from the population-based TwinsUK sample (N≈2000 for each factor), meta-analysis results from the METASTROKE consortium ischemic stroke genome-wide association study (12 389 cases, 62 004 controls), and genotype data for 9520 individuals from the WTCCC2 ischemic stroke study (3548 cases, 5972 controls—the largest METASTROKE subsample), we explored shared genetic risk for coagulation and stroke. We performed three analyses: (1) a test for excess concordance (or discordance) in single nucleotide polymorphism effect direction across coagulation and stroke, (2) an estimation of the joint effect of multiple coagulation-associated single nucleotide polymorphisms in stroke, and (3) an evaluation of common genetic risk between coagulation and stroke. Results— One coagulation factor, factor XIII subunit B (FXIIIB), showed consistent effects in the concordance analysis, the estimation of polygenic risk, and the validation with genotype data, with associations specific to the cardioembolic stroke subtype. Effect directions for FXIIIB-associated single nucleotide polymorphisms were significantly discordant with cardioembolic disease (smallest P=5.7×10−04); the joint effect of FXIIIB-associated single nucleotide polymorphisms was significantly predictive of ischemic stroke (smallest P=1.8×10−04) and the cardioembolic subtype (smallest P=1.7×10−04). We found substantial negative genetic covariation between FXIIIB and ischemic stroke (rG=−0.71, P=0.01) and the cardioembolic subtype (rG=−0.80, P=0.03). Conclusions— Genetic markers associated with low FXIIIB levels increase risk of ischemic stroke cardioembolic subtype.

[1]  C. Sudlow,et al.  Ischemic Stroke Is Associated with the ABO Locus: The EuroCLOT Study , 2013, Annals of neurology.

[2]  Alireza Moayyeri,et al.  The UK Adult Twin Registry (TwinsUK Resource) , 2012, Twin Research and Human Genetics.

[3]  Sang Hong Lee,et al.  Estimation of pleiotropy between complex diseases using single-nucleotide polymorphism-derived genomic relationships and restricted maximum likelihood , 2012, Bioinform..

[4]  Karen L. Mohlke,et al.  Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals , 2012, PLoS genetics.

[5]  Z. Koncz,et al.  Factor XIII, clot structure, thrombosis. , 2012, Thrombosis research.

[6]  M. Pirinen,et al.  Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke , 2012, Nature Genetics.

[7]  Stacey S. Cherny,et al.  Evaluating the effective numbers of independent tests and significant p-value thresholds in commercial genotyping arrays and public imputation reference datasets , 2011, Human Genetics.

[8]  Tom R. Gaunt,et al.  Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk , 2011, Nature.

[9]  P. Visscher,et al.  GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.

[10]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[11]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[12]  Tim D Spector,et al.  The UK Adult Twin Registry (TwinsUK) , 2006, Twin Research and Human Genetics.

[13]  J. Bamford,et al.  Coagulation factor XIII B subunit antigen, FXIIIVal34Leu genotype and ischaemic stroke in South Asians , 2005, Thrombosis and Haemostasis.

[14]  D. Nyholt.  A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. , 2004, American journal of human genetics.

[15]  Geoffrey Cloud,et al.  Evaluating the Genetic Component of Ischemic Stroke Subtypes: A Family History Study , 2003, Stroke.

[16]  M. Olivier.  A haplotype map of the human genome. , 2003, Nature.

[17]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[18]  Hugh S Markus,et al.  Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. , 2003, Brain : a journal of neurology.

[19]  A. Carter,et al.  Factor XIII A‐subunit concentration predicts outcome in stroke subjects and vascular outcome in healthy, middle‐aged men , 2002, British journal of haematology.

[20]  K. Christensen,et al.  Genetic Liability in Stroke: A Long-Term Follow-Up Study of Danish Twins , 2002, Stroke.

[21]  K. Furie,et al.  A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. , 2001, The New England journal of medicine.

[22]  T. Spector,et al.  The genetics of haemostasis: a twin study , 2001, The Lancet.

[23]  L. Almasy,et al.  Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. , 2000, American journal of human genetics.

[24]  J. Manson,et al.  Prospective study of aspirin use and risk of stroke in women. , 1999, Stroke.

[25]  A. Ichinose,et al.  Two genetic defects in a patient with complete deficiency of the b-subunit for coagulation factor XIII. , 1993, Blood.

[26]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[27]  K. Merikangas,et al.  A Study of Twins and Stroke , 1992, Stroke.

[28]  Blood Coagulation , 1941 .

[29]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[30]  C. Sudlow,et al.  Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies , 2012, The Lancet Neurology.

[31]  Azar,et al.  A COMPARISON OF WARFARIN AND ASPIRIN FOR THE PREVENTION OF RECURRENT ISCHEMIC STROKE , 2001 .

[32]  P. Grant,et al.  Association of a common polymorphism in the factor XIII gene with venous thrombosis. , 1999, Blood.

[33]  A. Carter,et al.  Association of a Common Polymorphism in the Factor XIII Gene with Myocardial Infarction , 1998, Thrombosis and Haemostasis.

[34]  R. Betts.  American Heart Association. , 1958, Hospital management.